Complications rise along with off-label use of BMP-2
Monday, September 6, 2010 - 11:14
in Health & Medicine
When the U.S. Food and Drug Administration in 2002 approved a product many thought would revolutionize back surgery, the agency did so despite concerns the product might cause serious side effects.